Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2014
09/24/2014EP2779993A1 Autoclavable suspensions of cyclosporin a form 2
09/24/2014EP2779992A1 Sustained action formulation of cyclosporin form 2
09/23/2014US8841476 Preparation of crystalline ezatiostat hydrochloride ansolvate form D
09/23/2014US8841429 Nucleic acid ligands against infectious prions
09/23/2014US8841427 Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof
09/23/2014US8841426 Mutant of granulocyte-colony stimulating factor (G-CSF) and chemically conjugated polypeptide thereof
09/23/2014US8841420 Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with Porphyromonas gingivalis
09/23/2014US8841417 IL-1 binding proteins
09/23/2014US8841416 Therapeutic nuclease compositions and methods
09/23/2014US8841414 Targeted delivery of therapeutic peptides by thermally responsive biopolymers
09/23/2014US8841260 Methods and compositions for treating Huntington's Disease
09/23/2014US8841259 Compositions and methods for treating vascular permeability
09/23/2014US8841258 Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation
09/23/2014US8841257 Inhibitors of STAT3 and uses thereof
09/23/2014US8841256 P2X7: inhibition of epithelial cancers and papillomas
09/23/2014US8841255 Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
09/23/2014US8841254 Method for treatment of anxiety
09/23/2014US8841253 Viral/bacterial toxin polypeptides and methods of using same
09/23/2014US8841252 Pharmaceutical formulation
09/23/2014US8841251 Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors
09/23/2014US8841250 Method for promoting muscle repair comprising administering G-CSF at the site of injury
09/23/2014US8841249 Growth hormones with prolonged in-vivo efficacy
09/23/2014US8841248 Manufacture of inter-alpha-inhibitor (IaIp) from plasma
09/23/2014US8841109 IGA1 protease polypeptide agents and uses thereof
09/23/2014US8841099 Cell-based production of nonulosonates
09/23/2014US8841081 Method of treating metastatic stage prostate cancer
09/23/2014US8840939 Vigna unguiculata seed extract and compositions containing same
09/23/2014US8840915 Pharmaceutical compositions for sustained release delivery of peptides
09/23/2014US8840913 Malleable multi-component implants and materials therefor
09/23/2014US8840905 Use of neurotoxin therapy for treatment of urologic and related disorders
09/23/2014US8840900 Chimeric bacteriophage lysin with activity against Staphylococci bacteria
09/23/2014US8840892 Method of administering antibiotic therapy for treating intracellular infectious diseases
09/23/2014US8840883 Metallo-protein and tocotrienol (MP-T3) compositions with non-protein-type metal chelator and uses thereof
09/23/2014US8840882 Modified ribonucleases
09/23/2014US8840879 Conjugates of hydroxyalkyl starch and a protein
09/23/2014US8840877 Polysaccharide-protein conjugates reversibly coupled via imine bonds
09/23/2014US8840874 Vascular delivery systems
09/23/2014CA2748860C Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
09/23/2014CA2720112C Suture line administration technique using botulinum toxins
09/23/2014CA2683009C Use of il-18 inhibitors
09/23/2014CA2658231C Method of producing recombinant tat-hoxb4h protein for use as a stimulant of hematopoiesis in vivo
09/23/2014CA2648460C Calcium phosphate complex and salts in oral delivery systems
09/23/2014CA2632544C Use of myostatin antagonist for treating the effects of hypogonadism
09/23/2014CA2588908C Induction of neurogenesis and stem cell therapy in combination with copolymer 1
09/23/2014CA2573512C Compositions for delivering peptide yy and pyy agonists
09/23/2014CA2548990C Toll-like receptor 4 (tlr4)-neutralizing antibodies
09/23/2014CA2534474C Methods for treating cardiovascular disease using a soluble ctla4 molecule
09/23/2014CA2490218C Extracorporeal photopheresis in combination with anti-tnf treatment
09/23/2014CA2447004C Antisense modulation of ptp1b expression
09/23/2014CA2441815C Method and composition for treatment of skeletal dysplasias
09/23/2014CA2398995C Lipid hydrolysis therapy for atherosclerosis and related diseases
09/23/2014CA2378182C Compositions and methods for the treatment of tumors
09/23/2014CA2218225C Glucagon-like peptide-2 and its therapeutic use
09/18/2014WO2014146130A2 Exercise machine
09/18/2014WO2014145975A2 Cellular discovery platform for neurodegenerative diseases
09/18/2014WO2014145817A2 Novel therapeutic target for the treatment of cancers and related therapies and methods
09/18/2014WO2014145776A2 Msp and its receptors in the therapy of amyotrophic lateral sclerosis
09/18/2014WO2014145755A1 Polyalkylene oxide valerate hemoglobin conjugates
09/18/2014WO2014145718A2 Peptides comprising non-natural amino acids and methods of making and using the same
09/18/2014WO2014145717A2 Laser devices utilizing alexandrite laser operating at or near its gain peak as shorter-wavelength pumping sources and methods of use thereof
09/18/2014WO2014145686A2 Novel cyclosporin derivatives and uses thereof
09/18/2014WO2014145683A1 Diabetes treatment
09/18/2014WO2014145593A2 Site 2 insulin analogues
09/18/2014WO2014145561A2 Hepcidin analogues and uses therof
09/18/2014WO2014145540A2 Systems and methods for providing alignment in total knee arthroplasty
09/18/2014WO2014145519A2 C1-inh compositions and methods for the prevention and treatment of disorders associated with c1 esterase inhibitor deficency
09/18/2014WO2014145507A1 A process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
09/18/2014WO2014145389A1 Inhibition of pulmonary fibrosis with nutlin-3a and peptides
09/18/2014WO2014145275A1 Methods for treatment of nephrotic syndrome and related conditions
09/18/2014WO2014145202A1 Methods and compositions for detecting binding to the pregnane x receptor
09/18/2014WO2014144969A1 Extracellular matrix-binding synthetic peptidoglycans
09/18/2014WO2014144903A1 Myostatin antagonism in human subjects
09/18/2014WO2014144895A1 Microcrystalline diketopiperazine compositions and methods
09/18/2014WO2014144871A1 Cytotoxic and anti-mitotic compounds, and methods of using the same
09/18/2014WO2014144859A1 Treatment method and product for uterine fibroids using purified collagenase
09/18/2014WO2014144795A1 Factor viii polypeptide formulations
09/18/2014WO2014144768A2 Bh4 stabilized peptides and uses thereof
09/18/2014WO2014144764A2 Method for producing factor h from a plasma precipitation fraction
09/18/2014WO2014144731A2 Compositions comprising hypoxia inducible factor-1 alpha and methods of using the same
09/18/2014WO2014144708A1 Peptides having reduced toxicity that stimulate cholesterol efflux
09/18/2014WO2014144686A1 Compunds for treating neurodegenerative proteinopathies
09/18/2014WO2014144623A1 Isolation of factor h from fraction i paste
09/18/2014WO2014144549A1 Factor ix polypeptide formulations
09/18/2014WO2014144521A1 Mitochondrial-derived peptide mots3 regulates metabolism and cell survival
09/18/2014WO2014144450A1 Methods for treating bleeding disorders using a platelet subpopulation
09/18/2014WO2014144330A1 Use of growth hormone or growth hormone receptor agonists to prevent or treat stress-sensitive psychiatric illness
09/18/2014WO2014144288A1 Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
09/18/2014WO2014144260A1 Peptide compositions
09/18/2014WO2014144231A1 Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
09/18/2014WO2014144004A1 Peptides with antifungal activity and methods of using the peptides
09/18/2014WO2014143992A1 Treating lysosomal storage disease
09/18/2014WO2014143943A1 Preparations containing hepatocyte growth factor and hyaluronic acid, and methods of making and using same
09/18/2014WO2014143806A1 Acid stable liposomal compositions
09/18/2014WO2014143763A2 Angiogenic compositions for wounds, articular joints and graft materials
09/18/2014WO2014143734A2 Chemical crosslinkers
09/18/2014WO2014143701A1 Chemical crosslinkers
09/18/2014WO2014143471A1 Oral electrolyte solution containing lactoferrin and uses thereof
09/18/2014WO2014143022A1 Compositions and methods for treating retinal disease
09/18/2014WO2014142933A1 Neuroimmunological response to stress
09/18/2014WO2014142764A1 New stable pentadecapeptide salts, a process for preparation thereof, a use thereof in the manufacture of pharmaceutical preparations and a use thereof in therapy
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 3163